SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

ARTL

Artelo Biosciences Inc.
NASDAQHealth Care

Latest close: 6.36 USD · Aug 31, 2026 · 1 year · split-adjusted

On the price, the facts of the public record◆Adverse 8-K filing◇Significant stake declared (13D)●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Oct 9, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  2. Aug 27, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  3. Aug 20, 2026Quarterly report · 10-QFiled by the company itself.Open the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year216
SEC filings on record4098 flagged findings
Reported transactions (Form 4)40since Dec 20, 2024 · and 1 other holding
Corporate events (8-K)30since May 1, 2025

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

Reverse splits in 5 years

4 reverse splits in 5 years (1:15 on Aug 10, 2022, 1:6 on Jun 13, 2025, 1:3 on Mar 10, 2026, 1:9 on Aug 31, 2026) · 1:2430 cumulative

The other times: of 226 securities that repeated a reverse split in 5 years, a year later the median was worth 0.10× the price on the day of the split; 177 lost more than half and 20 rose (226 with a price a year later).

Our own series, not the whole market: based on the splits we have on record (provider and SEC); an unrecorded one does not count. Historical distribution, not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 409)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Oct 9, 268-K ↗Current report · Other events
  • Aug 27, 268-K ↗Current report · Change in shareholder rights · Bylaws or fiscal year change · Communication to the market
  • Aug 20, 2610-Q/A ↗Quarterly report · amendment
  • Aug 14, 26SCHEDULE 13G/A ↗Passive stake · amendment
  • Aug 13, 26SCHEDULE 13G/A ↗Passive stake · Mitchell P. Kopin · 4.8% · event on Jun 30, 26 · amendment
  • Aug 12, 2610-Q ↗Quarterly report
  • Insider transaction · 6 Form 4 filingsshow all 6hide
  • Jul 17, 268-K ↗Current report · Shareholder vote results
  • Jul 16, 26DEFA14A ↗Shareholder meeting and votes
  • Jul 16, 26DEFA14A ↗Shareholder meeting and votes
  • Jul 2, 26DEFA14A ↗Shareholder meeting and votes
  • Jun 5, 26DEFA14A ↗Shareholder meeting and votes
  • Jun 5, 26DEF 14A ↗Shareholder meeting and votes
  • May 27, 268-K ↗Current report · Entered a material agreement
  • May 26, 26PRE 14A ↗Shareholder meeting and votes
  • May 26, 26424B5 ↗Securities offering
  • May 18, 26424B5 ↗Securities offering
  • May 15, 26CORRESP ↗Correspondence with the SEC
  • May 15, 268-K ↗Current report · A material agreement was terminated
  • May 15, 26SCHEDULE 13G ↗Passive stake · Armistice Capital, LLC · 10.0% · event on Mar 31, 26

409 filings on record, the oldest from Oct 8, 14.

Listing the 25 most recent filings of the 409 on record.

8-Ks, explained

Stress6Structure50Governance20
  • May 27, 26StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • May 15, 26StructureA material agreement was terminated8-K 1.02 ↗
  • Structure4 material agreements entered2026show all 4hide
    • Mar 30, 26StructureEntered a material agreement+4 more in the same filing8-K 1.01 ↗
    • Mar 26, 26StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
    • Mar 18, 26StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
    • Feb 5, 26StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Jan 16, 26StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Nov 25, 25StressListing notice (8-K 3.01)the filing reports the decision to delist8-K 3.01 ↗
  • Oct 31, 25StructureSold unregistered shares+3 more in the same filing8-K 3.02 ↗
  • Oct 27, 25GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Structure3 material agreements entered2025show all 3hide
    • Oct 17, 25StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
    • Oct 1, 25StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
    • Sep 5, 25StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Aug 20, 25StructureA material agreement was terminated+1 more in the same filing8-K 1.02 ↗
  • Aug 7, 25StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Aug 4, 25StructureSold unregistered shares+4 more in the same filing8-K 3.02 ↗
  • Jul 18, 25StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗

3 older filings not shown · The record reaches back to Jul 9, 15.

Notable in the record

Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.

The full record holds 6 stress filings.

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13D: stake and stated purpose

Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • Armistice Capital, LLC10.0%Mar 31, 26SCHEDULE 13G ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
  • Mitchell P. Kopin4.8%Jun 30, 26SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

Its sector and its market

Artelo Biosciences Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Artelo Biosciences Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Artelo Biosciences Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
Series with incidents in the period; the chart shows what could be kept.
SEC records
409 documents on file, from Oct 8, 2014 to Oct 9, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.